Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' CLARKEPEARSON DL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 40 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. BOENTE MP; BERCHUCK A; WHITAKER RS; KALEN A; XU FJ; CLARKEPEARSON DL; BELL RM; BAST RC
      SUPPRESSION OF DIACYLGLYCEROL LEVELS BY ANTIBODIES REACTIVE WITH THE C-ERBB-2 (HER-2 NEU) GENE-PRODUCT P185(C-ERBB-2) IN BREAST AND OVARIAN-CANCER CELL-LINES/

      Gynecologic oncology (Print)
    2. HOSKINS WJ; MCGUIRE WP; BRADY MF; KUCERA PR; PARTRIDGE EE; LOOK KY; CLARKEPEARSON DL; DAVIDSON M
      COMBINATION PACLITAXEL (TAXOL(R))-CISPLATIN VS CYCLOPHOSPHAMIDE-CISPLATIN AS PRIMARY THERAPY IN PATIENTS WITH SUBOPTIMALLY DEBULKED ADVANCED OVARIAN-CANCER

      International journal of gynecological cancer
    3. OMURA GA; BLESSING JA; VACCARELLO L; BERMAN ML; CLARKEPEARSON DL; MUTCH DG; ANDERSON B
      RANDOMIZED TRIAL OF CISPLATIN VERSUS CISPLATIN PLUS MITOLACTOL VERSUSCISPLATIN PLUS IFOSFAMIDE IN ADVANCED SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    4. CLIFFORD SL; KAMINETSKY CP; CIRISANO FD; DODGE R; SOPER JT; CLARKEPEARSON DL; BERCHUCK A
      RACIAL DISPARITY IN OVEREXPRESSION OF THE P53 TUMOR-SUPPRESSOR GENE IN STAGE-I ENDOMETRIAL CANCER

      American journal of obstetrics and gynecology
    5. MCGUIRE WP; HOSKINS WJ; BRADY MF; KUCERA PR; PARTRIDGE EE; LOOK KY; CLARKEPEARSON DL; DAVIDSON M
      COMPARISON OF COMBINATION THERAPY WITH PACLITAXEL TAXOL(R) AND CISPLATIN VERSUS CYCLOPHOSPHAMIDE AND CISPLATIN IN PATIENTS WITH SUBOPTIMAL STAGE-III AND STAGE-IV OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      International journal of gynecological cancer
    6. ALBERTS DS; LIU PY; HANNIGAN EV; OTOOLE R; WILLIAMS SD; YOUNG JA; FRANKLIN EW; CLARKEPEARSON DL; MALVIYA VK; DUBESHTER B; HOSKINS WJ; ADELSON MD; ALVAREZ RD; OSULLIVAN J; GARCIA DJ; SPARKS DB; QUADE J; ROTHENBERG ML
      PHASE-III STUDY OF INTRAPERITONEAL CISPLATIN-INTRAVENOUS CYCLOPHOSPHAMIDE VERSUS INTRAVENOUS CISPLATIN-INTRAVENOUS CYCLOPHOSPHAMIDE IN PATIENTS WITH OPTIMAL DISEASE STAGE-III OVARIAN-CANCER - A SWOG-GOG-ECOG INTERGROUP STUDY

      International journal of gynecological cancer
    7. MCGUIRE WP; HOSKINS WJ; BRADY MF; KUCERA PR; PARTRIDGE EE; LOOK KY; CLARKEPEARSON DL; DAVIDSON M
      CYCLOPHOSPHAMIDE AND CISPLATIN VERSUS PACLITAXEL AND CISPLATIN - A PHASE-III RANDOMIZED TRIAL IN PATIENTS WITH SUBOPTIMAL STAGE III IV OVARIAN-CANCER (FROM THE GYNECOLOGIC-ONCOLOGY-GROUP)/

      Seminars in oncology
    8. LOOK KY; BRUNETTO VL; CLARKEPEARSON DL; AVERETTE HE; MAJOR FJ; ALVAREZ RD; HOMESLEY HD; ZAINO RJ
      AN ANALYSIS OF CELL-TYPE IN PATIENTS WITH SURGICALLY STAGED STAGE IB CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      Gynecologic oncology
    9. MASSAD LS; BITTERMAN P; CLARKEPEARSON DL
      METASTATIC CLEAR-CELL ECCRINE HIDRADENOCARCINOMA OF THE VULVA - SURVIVAL AFTER PRIMARY SURGICAL RESECTION

      Gynecologic oncology
    10. ALBERTS DS; LIU PY; HANNIGAN EV; OTOOLE R; WILLIAMS SD; YOUNG JA; FRANKLIN EW; CLARKEPEARSON DL; MALVIYA VK; DUBESHTER B; ADELSON MD; HOSKINS WJ
      INTRAPERITONEAL CISPLATIN PLUS INTRAVENOUS CYCLOPHOSPHAMIDE VERSUS INTRAVENOUS CISPLATIN PLUS INTRAVENOUS CYCLOPHOSPHAMIDE FOR STAGE-III OVARIAN-CANCER

      The New England journal of medicine
    11. MCGUIRE WP; HOSKINS WJ; BRADY MF; KUCERA PR; PARTRIDGE EE; LOOK KY; CLARKEPEARSON DL; DAVIDSON M
      CYCLOPHOSPHAMIDE AND CISPLATIN COMPARED WITH PACLITAXEL AND CISPLATININ PATIENTS WITH STAGE-III AND STAGE-IV OVARIAN-CANCER

      The New England journal of medicine
    12. KOHLER MF; CARNEY P; DODGE R; SOPER JT; CLARKEPEARSON DL; MARKS JR; BERCHUCK A
      P53 OVEREXPRESSION IN ADVANCED-STAGE ENDOMETRIAL ADENOCARCINOMA

      American journal of obstetrics and gynecology
    13. STEHMAN FB; BUNDY BN; BALL H; CLARKEPEARSON DL
      SITES OF FAILURE AND TIMES TO FAILURE IN CARCINOMA OF THE VULVA TREATED CONSERVATIVELY - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      American journal of obstetrics and gynecology
    14. EVANS AC; SOPER JT; CLARKEPEARSON DL; BERCHUCK A; RODRIGUEZ GC; HAMMOND CB
      GESTATIONAL TROPHOBLASTIC DISEASE METASTATIC TO THE CENTRAL-NERVOUS-SYSTEM

      Gynecologic oncology
    15. BERCHUCK A; ANSPACH C; EVANS AC; SOPER JT; RODRIGUEZ GC; DODGE R; ROBBOY S; CLARKEPEARSON DL
      POSTSURGICAL SURVEILLANCE OF PATIENTS WITH FIGO STAGE I II ENDOMETRIAL ADENOCARCINOMA/

      Gynecologic oncology
    16. WOOLAS RP; CONAWAY MR; XU FJ; JACOBS IJ; YU YH; DALY L; DAVIES AP; OBRIANT K; BERCHUCK A; SOPER JT; CLARKEPEARSON DL; RODRIGUEZ G; ORAM DH; BAST RC
      COMBINATIONS OF MULTIPLE SERUM MARKERS ARE SUPERIOR TO INDIVIDUAL ASSAYS FOR DISCRIMINATING MALIGNANT FROM BENIGN PELVIC MASSES

      Gynecologic oncology
    17. SOPER JT; EVANS AC; RODRIGUEZ G; BERCHUCK A; CLARKEPEARSON DL; HAMMOND CB
      ETOPOSIDE PLATIN COMBINATION THERAPY FOR CHEMOREFRACTORY GESTATIONAL TROPHOBLASTIC DISEASE

      Gynecologic oncology
    18. SOPER JT; RODRIGUEZ G; BERCHUCK A; CLARKEPEARSON DL
      LONG AND SHORT GRACILIS MYOCUTANEOUS FLAPS FOR VULVO-VAGINAL RECONSTRUCTION AFTER RADICAL PELVIC-SURGERY - COMPARISON OF FLAP-SPECIFIC COMPLICATIONS

      Gynecologic oncology
    19. WEBER TM; SOSTMAN HD; SPRITZER CE; BALLARD RL; MEYER GA; CLARKEPEARSON DL; SOPER JT
      CERVICAL-CARCINOMA - DETERMINATION OF RECURRENT TURNER EXTENT VERSUS RADIATION CHANGES WITH MR-IMAGING

      Radiology
    20. LIU JR; CONAWAY M; RODRIGUEZ GC; SOPER JT; CLARKEPEARSON DL; BERCHUCK A
      RELATIONSHIP BETWEEN RACE AND INTERVAL TO TREATMENT IN ENDOMETRIAL CANCER

      Obstetrics and gynecology
    21. BENHAIM S; KAHN D; WEINER GJ; MADSEN MT; WAXMAN AD; WILLIAMS CM; CLARKEPEARSON DL; COLEMAN RE; MAGUIRE RT
      THE SAFETY AND PHARMACOKINETICS IN ADULT SUBJECTS OF AN INTRAVENOUSLYADMINISTERED TC-99M-LABELED 17 AMINO-ACID PEPTIDE (CYT-379)

      Nuclear medicine and biology
    22. SOPER JT; CLARKEPEARSON DL; BERCHUCK A; RODRIGUEZ G; HAMMOND CB
      5-DAY METHOTREXATE FOR WOMEN WITH METASTATIC GESTATIONAL TROPHOBLASTIC DISEASE

      Gynecologic oncology
    23. CLARKEPEARSON DL
      THE REASSESSMENT OF OVARIAN-CANCER IN COMPLETE CLINICAL REMISSION - WHAT ARE OUR GOALS

      Gynecologic oncology
    24. BERCHUCK A; KOHLER MF; HOPKINS MP; HUMPHREY PA; ROBBOY SJ; RODRIGUEZ GC; SOPER JT; CLARKEPEARSON DL; BAST RC
      OVEREXPRESSION OF P53 IS NOT A FEATURE OF BENIGN AND EARLY-STAGE BORDERLINE EPITHELIAL OVARIAN-TUMORS

      Gynecologic oncology
    25. SOPER JT; EVANS AC; CONAWAY MR; CLARKEPEARSON DL; BERCHUCK A; HAMMOND CB
      EVALUATION OF PROGNOSTIC FACTORS AND STAGING IN GESTATIONAL TROPHOBLASTIC TUMOR

      Obstetrics and gynecology
    26. RODRIGUEZ GC; HUGHES CL; SOPER JT; BERCHUCK A; CLARKEPEARSON DL; HAMMOND CB
      SERUM PROGESTERONE FOR THE EXCLUSION OF EARLY-PREGNANCY IN WOMEN AT RISK FOR RECURRENT GESTATIONAL TROPHOBLASTIC NEOPLASIA

      Obstetrics and gynecology
    27. MYERS ER; CLARKEPEARSON DL; OLT GJ; SOPER JT; BERCHUCK A
      PREOPERATIVE COAGULATION-TESTING ON A GYNECOLOGIC ONCOLOGY SERVICE

      Obstetrics and gynecology
    28. RODRIGUEZ GC; CLARKEPEARSON DL; SOPER JT; BERCHUCK A; SYNAN I; DODGE RK
      THE NEGATIVE PROGNOSTIC IMPLICATIONS OF THROMBOCYTOSIS IN WOMEN WITH STAGE IB CERVICAL-CANCER

      Obstetrics and gynecology
    29. SOPER JT; EVANS AC; CLARKEPEARSON DL; BERCHUCK A; RODRIGUEZ G; HAMMOND CB
      ALTERNATING WEEKLY CHEMOTHERAPY WITH ETOPOSIDE-METHOTREXATE-DACTINOMYCIN CYCLOPHOSPHAMIDE-VINCRISTINE FOR HIGH-RISK GESTATIONAL TROPHOBLASTIC DISEASE

      Obstetrics and gynecology
    30. CLARKEPEARSON DL; KOHLER MF; HURTEAU JA; ELBENDARY A
      SURGERY FOR ADVANCED OVARIAN-CANCER

      Clinical obstetrics and gynecology
    31. LUKES AS; KOHLER MF; PIEPER CF; KERNS BJ; BENTLEY R; RODRIGUEZ GC; SOPER JT; CLARKEPEARSON DL; BAST RC; BERCHUCK A
      MULTIVARIABLE ANALYSIS OF DNA-PLOIDY, P53, AND HER-2 NEU AS PROGNOSTIC FACTORS IN ENDOMETRIAL CANCER/

      Cancer
    32. XU FJ; YU YH; DALY L; ANSELMINO L; HASS GM; BERCHUCK A; RODRIGUEZ GC; SOPER JT; CLARKEPEARSON DL; HOLLIS D; BOYER C; BAST RC
      OVX1 AS A MARKER FOR EARLY-STAGE ENDOMETRIAL CARCINOMA

      Cancer
    33. CLARKEPEARSON DL
      POSTOPERATIVE VENOUS THROMBOSIS IN GYNECOLOGIC ONCOLOGY SURGERY - STUDY DESIGN - REPLY

      American journal of obstetrics and gynecology
    34. WOOLAS R; XU FJ; DALY L; SOPER JT; BERCHUCK A; RODRIGUEZ G; CLARKEPEARSON DL; BOYER CM; BAST RC
      SCREENING STRATEGIES FOR OVARIAN-CANCER

      Diagnostic oncology
    35. XU FJ; YU YH; DALY L; DESOMBRE K; ANSELMINO L; HASS GM; BERCHUCK A; SOPER JT; CLARKEPEARSON DL; BOYER C; LAYFIELD LJ; BAST RC
      OVX1 RADIOIMMUNOASSAY COMPLEMENTS CA-125 FOR PREDICTING THE PRESENCE OF RESIDUAL OVARIAN-CARCINOMA AT 2ND-LOOK SURGICAL SURVEILLANCE PROCEDURES

      Journal of clinical oncology
    36. SOISSON AP; OLT G; SOPER JT; BERCHUCK A; RODRIGUEZ G; CLARKEPEARSON DL
      PREVENTION OF SUPERFICIAL WOUND SEPARATION WITH SUBCUTANEOUS RETENTION SUTURES

      Gynecologic oncology
    37. KOHLER MF; NISHII H; HUMPHREY PA; SASKI H; MARKS J; BAST RC; CLARKEPEARSON DL; BOYD J; BERCHUCK A
      MUTATION OF THE P53 TUMOR-SUPPRESSOR GENE IS NOT A FEATURE OF ENDOMETRIAL HYPERPLASIAS

      American journal of obstetrics and gynecology
    38. CLARKEPEARSON DL; SYNAN IS; DODGE R; SOPER JT; BERCHUCK A; COLEMAN RE
      A RANDOMIZED TRIAL OF LOW-DOSE HEPARIN AND INTERMITTENT PNEUMATIC CALF COMPRESSION FOR THE PREVENTION OF DEEP VENOUS THROMBOSIS AFTER GYNECOLOGIC ONCOLOGY SURGERY

      American journal of obstetrics and gynecology
    39. WOOLAS RP; XU FJ; JACOBS IJ; YU YH; DALY L; BERCHUCK A; SOPER JT; CLARKEPEARSON DL; ORAM DH; BAST RC
      ELEVATION OF MULTIPLE SERUM MARKERS IN PATIENTS WITH STATE-I OVARIAN-CANCER

      Journal of the National Cancer Institute
    40. KOHLER MF; MARKS JR; WISEMAN RW; JACOBS IJ; DAVIDOFF AM; CLARKEPEARSON DL; SOPER JT; BAST RC; BERCHUCK A
      SPECTRUM OF MUTATION AND FREQUENCY OF ALLELIC DELETION OF THE P53 GENE IN OVARIAN-CANCER

      Journal of the National Cancer Institute


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 11:16:18